Profitability Ratios
| Ratio |
Value |
| GP Margin |
75.2% |
| EBIT Margin |
28.3% |
| EBITDA Margin |
40.1% |
| Operating Margin |
28.1% |
| Pretax Margin |
26.4% |
| Cont. Ops Margin |
23.1% |
| Net Margin |
23.1% |
| Bottom Line Margin |
23.1% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
1.04 |
| Quick Ratio |
0.84 |
| Solvency Ratio |
0.310 |
| Cash Ratio |
0.40 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
16.45 |
| PEG Ratio |
-0.96 |
| Forward PEG |
-0.96 |
| Price/Book |
4.46 |
| Price/Sales |
3.80 |
| Price/FCF |
14.23 |
| Price/Op Cash Flow |
11.15 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.3057 |
| Debt/Equity |
0.7097 |
| Debt/Capital |
0.4151 |
| Long-Term Debt/Capital |
0.3266 |
| Financial Leverage |
2.32 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
20.27 |
| Operating Cash Flow Ratio |
0.614 |
| Operating Cash Flow/Sales |
34.1% |
| Free Cash Flow/Operating Cash Flow |
78.4% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
2.08 |
| Interest Coverage |
14.0330 |
| Short-Term Operating Cash Flow Coverage |
2.18 |
| Operating Cash Flow Coverage |
0.56 |
| Capital Expenditure Coverage |
4.62 |
| Dividend + Capital Expenditure Coverage |
1.54 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
63.8472% |
| Dividend Yield |
3.8819% |
| Dividend Yield % |
3.8819% |
| Dividend Per Share |
3.7775 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
25.63 |
| EPS |
5.916 |
| Debt/Share |
16.0009 |
| Cash/Share |
6.62 |
| Book Value/Share |
21.86 |
| Tangible BV/Share |
-3.74 |
| Equity/Share |
21.82 |
| Operating Cash Flow/Share |
8.730 |
| Capital Expenditure/Share |
1.890 |
| FCF/Share |
6.840 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.875 |
| Earnings Before Tax/EBIT |
0.938 |
| Price/Fair Value |
4.46 |
| Debt/Market Cap |
0.1500 |
| Effective Tax Rate |
12.5% |
| Enterprise Value Multiple |
10.44 |
NVS - Novartis AG